Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:55 PM
Ignite Modification Date:
2025-12-24 @ 1:55 PM
NCT ID:
NCT06947395
Eligibility Criteria:
Inclusion Criteria:
* Informed consent available
* \> 45 years of age
* PDAC cases
* Treatment-naïve, pathologically confirmed PDAC Stage I or Stage II
* Sporadic or familial/genetic PDAC
* Controls
* Individuals at high risk for PDAC because of their familial and/or genetic history
* Individuals at high risk for PDAC because of pancreatic cysts between 1.0cm and 3.0cm in diameter.
* Controls will be selected to have similar demographic features (age/gender) to PDAC patients
Exclusion Criteria:
* Prior treatment for PDAC (i.e., prior resection, radiotherapy, or chemotherapy)
* Current immunosuppressive (e.g., systemic steroid therapy) or chemotherapy
* Major surgery or significant trauma within 12 weeks prior to blood sample collection
* Non-PDAC malignancies within 3 years prior to sample collection squamous or basal cell skin carcinoma is not an exclusion criteria)
* Control patients who currently have
* biliary obstruction secondary to gallstones
* prior diagnosis or imaging evidence of chronic pancreatitis
* cystic pancreatic lesions \>3.0 cm in diameter or showing worrisome features according to Fukuoka Consensus Guidelines.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
45 Years
Study:
NCT06947395
Study Brief:
Protocol Section:
NCT06947395